Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

A V Rajwade: Servicing Dubai's growth
A V Rajwade / New Delhi December 07, 2009, 0:32 IST

New Satyam chargesheet: Khurshid says court to decide
Amid reports that the Satyam accounting fraud could be as high as Rs 14,000 crore, nearly double of what was confessed by its founder B Ramalinga Raju, the government today remained tight-lipped and said the real amount would be brought before the court of law.

News of the day

Heavy industry PSUs have to go in for energy audits
The government today said all state-owned companies under the Department of Heavy Industry should go in for energy audits to help cut costs and reduce pollution.
Public Company

Glenmark gets US nod for ointment

Drug firm Glenmark Pharmaceuticals today said it has received approval from the US Food and Drug Administration (FDA) for an ointment used in treating skin problems. - Sun Pharma: Inclement weather - US FDA seizes drugs at Sun unit - Glenmark gets US regulatory nod for anti-hypertension tablets - Aurobindo Phrama gets USFDA nod for veterinary drug - Orchid Pharmaceuticals receive FDA nod for anti-migraine tablets - Ranbaxy: Catching the FDA flu The company had filed an abbreviated new drug application, which is for generic drugs only. The company has got the approval through its US-based subsidiary Glenmark Generics and will launch the product in the US market immediately, Glenmark said in a filing to the Bombay Stock Exchange. "Today"s approval (complements) Glenmark"s recent launch of Alcometasone Dipropionate cream and allows the company to provide superior service to their customers by offering complete line of Alclometasone topical products," the filing said. Alcometasone Dipropionate is a generic version of GSK"s Aclovate and the company will manufacture it at its US FDA approved manufacturing facility in Baddi, Himachal Pradesh.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009